Magnimus Pharmaceutical Industries Private Limited - Company Profile

It is a pharma private limited company based in Amritsar, Punjab, India, established in 2019.
2019 Amritsar, Punjab, India Active
Last Updated:
Access Report
About Magnimus Pharmaceutical Industries Private Limited

Magnimus Pharmaceutical Industries Private Limited, a active private limited company, was established on 21 February 2019 in Amritsar, Punjab, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24110PB2019PTC049085. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Employing 3 professional, Its leadership includes Karan Goyal (Director), Subhash Chander (Director). Past directors included Karan Goyal, Sarvinder Singh, Subhash Chander. It holds ₹1.53 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 8Th Km Stone, G.T. Road, Vill. Rampura P.O. Jheete Kalan, Daburji, Amritsar, Punjab, 143115.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110PB2019PTC049085

  • Registration Number

    049085

  • Incorporation Date

    21 February 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 9 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.53 Cr
  • Revenue Growth **** 170.11%
  • Profit Growth **** 42.33%
  • Ebitda **** 111.12%
  • Net Worth 40.60%
  • Total Assets **** 232.36%
Company report

Magnimus Pharmaceutical Industries Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Magnimus Pharmaceutical Industries Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Magnimus Pharmaceutical Industries Private Limited?
Current Directors
Name Designation Appointment Date Status
Karan Goyal Director 24 May 2023 Current
Subhash Chander Director 24 May 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Managing Director 08 Oct 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Director 13 Jun 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Magnimus Pharmaceutical Industries.

Magnimus Pharmaceutical Industries Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 170.11% increase. The company also saw a substantial improvement in profitability, with a 42.33% increase in profit. The company's net worth Soared by an impressive increase of 40.6%.

Magnimus Pharmaceutical Industries revenue growth over time
Magnimus Pharmaceutical Industries profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 170.11%
*******
*******
*******
*******
Revenue from Operations
*******
 166.98%
*******
*******
*******
*******
Total Assets
*******
 232.36%
*******
*******
*******
*******
Profit or Loss
*******
 42.33%
*******
*******
*******
*******
Net Worth
*******
 40.60%
*******
*******
*******
*******
EBITDA
*******
 111.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Magnimus Pharmaceutical Industries?

Unlock access to Magnimus Pharmaceutical Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹15,300,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 1.53 Cr
Latest Charge Details
Date Lender Amount Status
20 Mar 2023 Others ₹5.50 M Open
29 Jul 2022 Others ₹9.80 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Magnimus Pharmaceutical Industries?

Magnimus Pharmaceutical Industries has a workforce of 3 employees as of Nov 19, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Magnimus Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnimus Pharmaceutical Industries's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Magnimus Pharmaceutical Industries
Recent Activity within the Organization
  • Annual General Meeting

    The activity Magnimus Pharmaceutical Industries Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Magnimus Pharmaceutical Industries Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.

  • Director Appointment

    Progress on Karan Goyal was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 9 months . was documented.

  • Director Appointment

    Subhash Chander was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 5.50 M with Charge ID 100694925 was registered on 20 Mar 2023. was documented.

  • Charges

    A charge with Others amounted to Rs. 9.80 M with Charge ID 100607933 was registered on 29 Jul 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Magnimus Pharmaceutical Industries Private Limited?

The CIN of Magnimus Pharmaceutical Industries Private Limited is U24110PB2019PTC049085.

Where is Magnimus Pharmaceutical Industries Private Limited headquartered?

Magnimus Pharmaceutical Industries Private Limited is headquartered at 8Th Km Stone, G.T. Road, Vill. Rampura P.O. Jheete Kalan, Daburji, Amritsar, Punjab, 143115.

When was Magnimus Pharmaceutical Industries Private Limited incorporated?

Magnimus Pharmaceutical Industries Private Limited was incorporated on 21 February 2019.

Who are the current directors of Magnimus Pharmaceutical Industries Private Limited?

The current directors of Magnimus Pharmaceutical Industries Private Limited are

What is the primary industry of Magnimus Pharmaceutical Industries Private Limited?

The primary industry of Magnimus Pharmaceutical Industries Private Limited is Trade.

Is Magnimus Pharmaceutical Industries Private Limited a listed company?

Magnimus Pharmaceutical Industries Private Limited is unlisted.

What is the capital structure of Magnimus Pharmaceutical Industries Private Limited?

The authorized capital of Magnimus Pharmaceutical Industries Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available